AstraZeneca Pharma India receives permission for sale and distribution of Trastuzumab deruxtecan
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Subscribe To Our Newsletter & Stay Updated